These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


458 related items for PubMed ID: 21972160

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what?
    Shah R, Thomson A, Atianzar K, Somma K, Mehra A, Clavijo L, Matthews RV, Shavelle DM.
    Cardiovasc Revasc Med; 2012; 13(2):101-5. PubMed ID: 22406055
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO, Singh IM, Holmes DR, Pulido JN, Park SJ, Rihal CS.
    Catheter Cardiovasc Interv; 2012 Nov 01; 80(5):728-34. PubMed ID: 22378485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience.
    Schwartz BG, Ludeman DJ, Mayeda GS, Kloner RA, Economides C, Burstein S.
    Cardiol Res; 2012 Apr 01; 3(2):54-66. PubMed ID: 28348673
    [Abstract] [Full Text] [Related]

  • 6. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrøm T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engström AE, Henriques JP.
    J Am Coll Cardiol; 2009 Dec 15; 54(25):2430-4. PubMed ID: 20082934
    [Abstract] [Full Text] [Related]

  • 7. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
    Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS.
    J Invasive Cardiol; 2008 Feb 15; 20(2):67-72. PubMed ID: 18252970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F, Paloscia L, Trani C, Mascellanti M, Mongiardo R, Materazzo G, Niccoli G, Di Marco M, Leone AM, Porto I, Mazzari MA, Rebuzzi AG, Schiavoni G, Crea F.
    J Cardiovasc Med (Hagerstown); 2008 Oct 15; 9(10):1004-10. PubMed ID: 18799962
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI, Kakkar A, Torguson R, Li Y, Ben-Dor I, Collins SD, Lemesle G, Maluenda G, Xue Z, Scheinowitz M, Kaneshige K, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Cardiovasc Revasc Med; 2010 Oct 15; 11(2):91-7. PubMed ID: 20347798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S, Chechi T, Giuliani G, Lilli A, Consoli L, Spaziani G, Giannotti F, Margheri M.
    Minerva Cardioangiol; 2008 Aug 15; 56(4):391-9. PubMed ID: 18614983
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
    O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M.
    Circulation; 2012 Oct 02; 126(14):1717-27. PubMed ID: 22935569
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.